Search

Displaying results 8671 - 8680 of 10000 in total
  1. Drug

    CLBS12

    go.drugbank.com/drugs/DB18192
    Investigational

    CLBS12 is a GCSF-mobilized autologous cell therapy derived from CD34+ cells being investigated for the treatment of Buerger’s disease.

  2. Drug

    GX-G8

    go.drugbank.com/drugs/DB18196
    Experimental

    GX-G8 is a long-acting glucagon-like peptide 2 (GLP-2) being investigated for the treatment of short bowel syndrome.

  3. Drug

    ST-003

    go.drugbank.com/drugs/DB18197
    Experimental

    ST-003 is a novel galanin receptor inhibitor being investigated for the treatment of primary sclerosing cholangitis.

  4. Drug

    FCX-013

    go.drugbank.com/drugs/DB18218
    Investigational

    FCX-013 consists of human dermal fibroblasts genetically modified with a lentiviral vector expressing metalloproteinase-1 (MMP-1).

  5. Drug

    CKD-504

    go.drugbank.com/drugs/DB18235
    Investigational

    CKD-504 is a novel, selective histone deacetylase 6 inhibitor.

  6. Drug

    MRT5005

    go.drugbank.com/drugs/DB18260
    Investigational

    MRT5005 is a human cystic fibrosis transmembrane conductance regulator (hCFTR) messenger RNA (mRNA) complexed with branched polyethyleneimine (bPEI).

  7. Drug

    MPB-1523

    go.drugbank.com/drugs/DB18334
    Investigational

    MPB-1523 is a contrast agent comprising PEGylated iron oxide nanoparticles.[L48161]

  8. Drug

    NXC680

    go.drugbank.com/drugs/DB18366
    Experimental

    NXC680 is a small molecule under investigation for the treatment of idiopathic pulmonary fibrosis (IPF).

  9. Drug

    Zafiride

    go.drugbank.com/drugs/DB18371
    Investigational

    Zafiride is a human tumor necrosis factor coupled to the C terminus of CNGRCG peptide.

  10. Drug

    Sigvotatug Vedotin

    go.drugbank.com/drugs/DB18377
    Investigational

    Sigvotatug vedotin (SGN-B6A) is a humanized immunoglobulin G1 anti-integrin beta-6 monoclonal antibody conjugated to monomethyl auristatin E.